Zum Seiteninhalt springen

The talk will be held in English and is free of charge and open to the public.


Richard J. Ablin, PhD, DSc
Professor of Pathology at the University of Arizona College of Medicine, Arizona Cancer Center, and BIO5 Institute in Tucson, AZ, USA. A pioneer in prostate cancer research and immunotherapy, Dr. Ablin discovered the PSA in 1970 and for decades has fought against the misuse of his discovery for screening of prostate cancer.


Prof. Dr. Ulrich Dirnagl
Founding Director of QUEST - The Center for Transforming Biomedical
Research, Berlin Institute of Health

Panel discussion

Prof. Gerd Gigerenzer
Director at the Max Planck Institute for Human Development, Director of the Harding Center for Risk Literacy in Berlin

Prof. Dr. Dr. Tobias Kurth
Director of the Institute of Public Health
Charité – Universitätsmedizin Berlin

Prof. Dr. med. Carsten Stephan
Clinic for Urology
Charité - Universitätsmedizin Berlin


July 4, 2017
16.30 pm


Charité Campus Mitte (CCM)
Sauerbruchweg 3